Effect of intensive lifestyle modification in patients with obesity (even extreme obesity) on cardiometabolic parameters

Czech version

Authors: Adela Penesová ¹; Jana Babjaková ²; Viktor Bielik ³; Žofia Rádiková ¹; Libuša Kubáňová ^1,3
Authors‘ workplace: Ústav klinického a translačného výskumu, Biomedicínske centrum SAV, v. v. i., Bratislava ¹; Ústav hygieny LF UK v Bratislave ²; Katedra biologických a lekárskych vied, Fakulta telesnej výchovy a športu UK v Bratislave ³
Published in: Diab Obez 2022; 22(44): 95-101
Category:

Overview

Management of extreme obesity (with body mass index (BMI) > 40 kg/m²), requires a multidisciplinary approach to treatment. According to the recommendations of the European Association for the Study of Obesity (EASO), patients with extreme obesity require not only lifestyle changes but also pharmacotherapy and an early indication for bariatric surgery. Therefore, the aim of our work was to monitor the effect of intensivelifestyle changes (diet and physical activity) on obese patients of various degrees on cardiometabolic parameters. Methods: Forty-one patients with obesity class I and II (group A – 28 females/13 males; age: 42.9 ± 11.8 years; BMI 31.4 ± 6.3 kg/m²) and 13 patients with class III obesity (group B – 6 females/7 males; age: 34.6 ± 9.7 years; BMI 51.5 ± 8.0 kg/m²) were involved to the study. Lifestyle intervention was proposed after the clinical examination, consisting of individual counselling sessions. As part of the management, each patient received an individualized diet plan and also a plan of physical activity, which took place under the supervision of an experienced trainer. Results: After 6 months of intervention, patients achieved a weight reduction of 7–39 % of their original body weight by changing their lifestyle. Many cardiometabolic parameters such as blood pressure levels, glycemia, cholesterol levels, liver parameters, etc. have been significantly and positively changed. Conclusions: Preliminary results of our study confirm the positive effect of lifestyle changes on weight loss even in patients with extreme obesity. However, long-term follow-up, dispensarisation in specialized out-patients clinics, and early indication for bariatric surgery are necessary (which could not be fully performed during the COVID-19 pandemic). The Center for Obesity Management (CMO) at the Biomedical Center of the Slovak Academy of Sciences is currently being built, and should also contribute to this.

Keywords:

Physical activity – nutritional intervention – bariatric surgery – antiobesitics – extreme obesity

Sources

1. Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected – obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol 2021; 17(3): 135–149. Dostupné z DOI: <http://dx.doi.org/10.1038/s41574–020–00462–1>.

2. WHO. Controlling the global obesity epidemic. Dostupné z WWW: <https://www.who.int/activities/controlling-the-global-obesity-epidemic>.

3. Informace dostupné z WWW: <https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Glossary:Obesity>.

4. Tichá Ľ, Regecová V, Šebeková K et al. Prevalence of overweight/obesity among 7-year-old children-WHO Childhood Obesity Surveillance Initiative in Slovakia, trends and differences between selected European countries. Eur J Pediatr 2018; 177(6): 945–953. Dostupné z DOI: <http://dx.doi.org/10.1007/s00431–018–3137–7>.

5. Ostrihoňová T, Rimárová K, Bérešová J et al. Prevalence and Trends of Metabolic Syndrome in Slovakia during the Period of 2003–2012. Cent Eur J Public Health 2017; 25(4): 313–320. Dostupné z DOI: <http://dx.doi.org/10.21101/cejph.a4968>.

6. ÚVZ SR. 4. marec – Svetový deň obezity 2021. Dostupné z WWW: <https://www.uvzsr.sk/index.php?option=com_content&view=article&id=4641:uvz-sr-4-marec-svetov y-de-obezity-2021&catid=56:tlaove-spravy&Itemid=62>.

7. Tremmel M, Gerdtham UG, Nilsson PM et al. Economic Burden of Obesity: A Systematic Literature Review. Int J Environ Res Public Health 2017; 19; 14(4):435. Dostupné z DOI: <http://dx.doi.org/10.3390/ijerph14040435>.

8. Kitahara CM, Flint AJ, Berrington de Gonzalez A et al. Association between class III obesity (BMI of 40–59 kg/m²) and mortality: a pooled analysis of 20 prospective studies. PLoS Med 2014; 11(7): e1001673. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pmed.1001673>.

9. Klenk J, Rapp K, Ulmer H et al. Changes of body mass index in relation to mortality: results of a cohort of 42,099 adults. PLoS One 2014; 9(1): e84817. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0084817>.

10. Kivimäki M, Kuosma E, Ferrie JE et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health 2017; 2(6): e277-e285. Dostupné z DOI: <http://dx.doi.org/10.1016/S2468–2667(17)30074–9>.

11. Yumuk V, Tsigos C, Fried M et al. [Obesity Management Task Force of the European Association for the Study of Obesity]. European Guidelines for Obesity Management in Adults. Obes Facts 2015; 8(6): 402–424. Dostupné z DOI: <http://dx.doi.org/10.1159/000442721>.

12. Fried M, Yumuk V, Oppert JM et al. [IFSO-EC, EASO and EASO OMTF]. Interdisciplinary European Guidelines on metabolic and bariatric surgery. Obes Surg 2014; 24(1): 42–55. Dostupné z DOI: <http://dx.doi.org/ 10.1007/s11695–013–1079–8>.

13. Agrawal S (ed). Obesity, Bariatric and Metabolic Surgery: A Practical Guide. Springer: Cham 2016: 603–611. ISBN 978–3-319–04342–5. Dostupné z DOI: <https://doi.org/10.1007/978–3-319–04343–2>.

14. Fábryová Ľ et al. 2021 Štandardný diagnostický a terapeutický postup na komplexný manažment nadhmotnosti/obezity v dospelom veku. Dostupné z WWW: <https://www.standardnepostupy.sk/standardy-obezitologia/#>.

15. Diéty nefungujú, zmena návykov áno! Dostuupné z WWW: <https://www.planeat.sk/>.

16. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from International Diabetes Federation. Diabet Med 2006; 23(5): 469–480. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1464–5491.2006.01858.x>.

17. Penesová A, Páleník M, Babjaková J ed al. Špecifiká manažmentu extrémne obézneho pacienta (Specifics of extremely obese patient management). In: Dni praktickej obezitológie a metabolického syndrómu: zborník vedeckých prác. Collegium Humanum Warsaw Management University: 2020: 296–311. ISBN 978–83–958245–0-0.

18. Bajer B, Rádiková Ž, Havranová A et al. Effect of 8-weeks intensive lifestyle intervention on LDL and HDL subfractions. Obes Res Clin Pract 2019; 13(6): 586–593. Dostupné z DOI: <http://dx.doi.org/10.1016/j.orcp.2019.10.010>.

19. [American Diabetes Association]. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care 2021; 44(Suppl 1): S15-S33. Dostupné z DOI: <http://dx.doi.org/10.2337/dc21-S002>. Erratum in: Diabetes Care 2021; 44(9): 2182. Dostupné z DOI: <http://dx.doi.org/10.2337/dc21-ad09>.

20. Rydén L, Grant PJ, Anker SD et al. [Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD)]. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD –summary. Diab Vasc Dis Res 2014; 11(3): 133–73. Dostupné z DOI: <http://dx.doi.org/10.1177/1479164114525548>.

21. Davies MJ, D’Alessio DA, Fradkin J et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018; 41(12): 2669–2701. Dostupné z DOI: <http://dx.doi.org/10.2337/dci18–0033>.

22. Cosentino F, Grant PJ, Aboyans V et al. [ESC Scientific Document Group]. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41(2): 255–323. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehz486>.

23. Bajaj S. RSSDI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2017. Int J Diabetes Dev Countries 2018, 38(Suppl 1): 1–115. Dostupné z DOI: <http://dx.doi.org/10.1007/s13410–018–0604–7>.

24. Taheri S, Zaghloul H, Chagoury O et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 2020; 8(6): 477–489. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213–8587(20)30117–0>.

25. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Rev Esp Cardiol (Engl Ed) 2019; 72(2): 160. Dostupné z DOI: <http://dx.doi.org/10.1016/j.rec.2018.12.004>.

26. Millen BE, Wolongevicz DM, Nonas CA et al. 2013 American Heart Association/American College of Cardiology/the Obesity Society Guideline for the Management of Overweight and Obesity in Adults: implications and new opportunities for registered dietitian nutritionists. J Acad Nutr Diet 2014; 114(11): 1730–1735. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jand.2014.07.033>.

27. Mach F, Baigent C, Catapano AL et al. [ESC Scientific Document Group]. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41(1): 111–188. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehz455>.

28. Visseren FLJ, Mach F, Smulders YM et al. [ESC National Cardiac Societies; ESC Scientific Document Group]. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34): 3227–3337. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehab484>.

29. Gilardini L, Redaelli G, Croci M et al. Effect of a Modest Weight Loss in Normalizing Blood Pressure in Obese Subjects on Antihypertensive Drugs. Obes Facts 2016; 9(4): 251–258. Dostupné z DOI: <http://dx.doi.org/10.1159/000445504>.

30. Cohen JB. Hypertension in Obesity and the Impact of Weight Loss. Curr Cardiol Rep 2017; 24; 19(10): 98. Dostupné z DOI: <http://dx.doi.org/10.1007/s11886–017–0912–4>.

31. Fogarasi A, Gonzalez K, Dalamaga M et al. The Impact of the Rate of Weight Loss on Body Composition and Metabolism. Curr Obes Rep 2022; 11(2): 33–44. Dostupné z DOI: <http://dx.doi.org/10.1007/s13679–022–00470–4>.

32. Neter JE, Stam BE, Kok FJ et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003; 42: 878–884. Dostupné z DOI: <http://dx.doi.org/10.1161/01.HYP.0000094221.86888.AE>.

33. Williams B, Mancia G, Spiering W et al. [List of authors/Task Force members]. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2018; 36(12): 2284–2309. Dostupné z DOI: <http://dx.doi.org/10.1097/HJH.0000000000001961>. Erratum in J Hypertens 2019; 37(2): 456. Dostupné z DOI: <http://dx.doi.org/10.1097/HJH.0000000000002026>.

34. Piepoli MF, Hoes AW, Agewall S et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 2016; 252: 207–274. Dostupné z DOI: <http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.037>.

35. Lindström J, Louheranta A, Mannelin M et al. [Finnish Diabetes Prevention Study Group]. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003; 26(12): 3230–3236. Dostupné z DOI: <http://dx.doi.org/10.2337/diacare.26.12.3230>.

36. Delahanty LM, Pan Q, Jablonski KA et al. [Diabetes Prevention Program Research Group]. Effects of Weight Loss, Weight Cycling, and Weight Loss Maintenance on Diabetes Incidence and Change in Cardiometabolic Traits in the Diabetes Prevention Program. Diabetes Care 2014; 37(10): 2738–2745. Dostupné z DOI: <http://dx.doi.org/10.2337/dc14–0018>.

37. Penn L, White M, Lindström J et al. Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PLoS One 2013; 8(2): e57143. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0057143>.

38. Pi-Sunyer X. The Look AHEAD Trial: A Review and Discussion Of Its Outcomes. Curr Nutr Rep 2014; 3(4): 387–391. Dostupné z DOI: <http://dx.doi.org/10.1007/s13668–014–0099-x>.

39. Perreault L, Pan Q, Mather KJ et al. [Diabetes Prevention Program Research Group]. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012; 379(9833): 2243–2251. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(12)60525-X>.

40. Gibbs BB, Brancati FL, Chen H et al. [Look AHEAD Research Group]. Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study. Eur J Prev Cardiol 2014; 21(5): 608–617. Dostupné z DOI: <http://dx.doi.org/10.1177/2047487312462823>.

41. Gong Q, Zhang P, Wang J et al. [Da Qing Diabetes Prevention Study Group]. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol 2019; 7(6): 452–461. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213–8587(19)30093–2>.

42. Hamdy O, Tasabehji MW, Elseaidy T et al. Fat Versus Carbohydrate-Based Energy-Restricted Diets for Weight Loss in Patients With Type 2 Diabetes. Curr Diab Rep 2018; 18(12): 128. Dostupné z DOI: <http://dx.doi.org/10.1007/s11892–018–1103–4>.

43. Hu T, Mills KT, Yao L et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2012; 176 Suppl 7(Suppl 7): S44-S54. Dostupné z DOI: <http://dx.doi.org/10.1093/aje/kws264>.

44. Goldenberg JZ, Day A, Brinkworth GD et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021; 372: m4743. Dostupné z DOI: <http://dx.doi.org/10.1136/bmj.m4743>.

45. Jovanovski E, Mazhar N, Komishon A et al. Can dietary viscous fiber affect body weight independently of an energy-restrictive diet? A systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2020; 111(2): 471–485. Dostupné z DOI: <http://dx.doi.org/10.1093/ajcn/nqz292>.

46. Bozzetto L, Costabile G, Della Pepa G et al. Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk. Nutrients 2018; 10(7): 943. Dostupné z DOI: <http://dx.doi.org/10.3390/nu10070943>.